Dolby Laboratories (NYSE:DLB – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Monday. Separately, Rosenblatt Securities reaffirmed a “buy” rating and set a $98.00 price objective on shares of Dolby Laboratories in a research report on Monday, December 11th. […]
Column Capital Advisors LLC boosted its holdings in shares of Dolby Laboratories, Inc. (NYSE:DLB – Free Report) by 20.1% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,462 shares of the electronics maker’s stock after purchasing an additional 245 shares […]
Advisor OS LLC raised its position in Dolby Laboratories, Inc. (NYSE:DLB – Free Report) by 5.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,514 shares of the electronics maker’s stock after purchasing an additional 496 shares during the quarter. Advisor OS […]
Dolby Laboratories, Inc. (NYSE:DLB – Get Free Report) CEO Kevin J. Yeaman sold 9,030 shares of the stock in a transaction that occurred on Wednesday, January 17th. The stock was sold at an average price of $83.51, for a total value of $754,095.30. Following the transaction, the chief executive officer now owns 83,721 shares in […]
Allspring Global Investments Holdings LLC grew its stake in shares of Dolby Laboratories, Inc. (NYSE:DLB – Free Report) by 12.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 155,033 shares of the electronics maker’s stock after buying an additional 17,292 shares […]